Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.
about
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Bevacizumab plus hypofractiona ...... en-label, phase II ARTE trial.
@en
Bevacizumab plus hypofractiona ...... en-label, phase II ARTE trial.
@nl
type
label
Bevacizumab plus hypofractiona ...... en-label, phase II ARTE trial.
@en
Bevacizumab plus hypofractiona ...... en-label, phase II ARTE trial.
@nl
prefLabel
Bevacizumab plus hypofractiona ...... en-label, phase II ARTE trial.
@en
Bevacizumab plus hypofractiona ...... en-label, phase II ARTE trial.
@nl
P2093
P50
P356
P1433
P1476
Bevacizumab plus hypofractiona ...... en-label, phase II ARTE trial.
@en
P2093
A F Hottinger
D Schrimpf
E J Rushing
F Caparrotti
G Reifenberger
H-G Wirsching
P304
P356
10.1093/ANNONC/MDY120
P50
P577
2018-04-10T00:00:00Z